IP Verse

Nucleobase Editors And Uses Thereof - EP3365356

The patent EP3365356 was granted to President And Fellows OF Harvard College on Jun 28, 2023. The application was originally filed on Oct 22, 2016 under application number EP16791744A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3365356

PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Application Number
EP16791744A
Filing Date
Oct 22, 2016
Status
Granted And Under Opposition
May 26, 2023
Grant Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMar 27, 2024CARPMAELS & RANSFORDWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2000EP11690
EXAMINATIONEP3115457
INTERNATIONAL-SEARCH-REPORTWO2015089406
INTERNATIONAL-SEARCH-REPORTWO2015133554
INTERNATIONAL-SEARCH-REPORTWO2016183438
OPPOSITIONEP3115457
OPPOSITIONWO2014186686
OPPOSITIONWO2015089406
OPPOSITIONWO2015133554
OPPOSITIONWO2016183438

Non-Patent Literature (NPL) Citations (69) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALI, HEMATOL., (2014), vol. 93, pages 381 - 384
DESCRIPTION- CHIPEV ET AL., CELL, (1992), vol. 70, pages 821 - 828
DESCRIPTION- CONG, L. ET AL., "Multiplex genome engineering using CRISPR/Cas systems", SCIENCE, (2013), vol. 339, pages 819 - 823
DESCRIPTION- FUJISAWA, BLOOD, (2007), vol. 109, pages 2903 - 2911
DESCRIPTION- GALLO, J. ALZHEIMER'S DISEASE, (2011), vol. 25, pages 425 - 431
DESCRIPTION- IRRTHUM ET AL., AM. J. HUM. GENET., (2000), vol. 67, pages 295 - 301
DESCRIPTION- JINEK ET AL., SCIENCE, (2012), vol. 337, pages 816 - 821
DESCRIPTION- JINEK M.; CHYLINSKI K.; FONFARA I.; HAUER M.; DOUDNA J.A.; CHARPENTIER E., SCIENCE, (2012), vol. 337, pages 816 - 821
DESCRIPTION- JINEK, M. ET AL., "RNA-programmed genome editing in human cells", ELIFE, (2013), vol. 2, page E00471
DESCRIPTION- JINEK, SCIENCE, (2012), vol. 337, pages 816 - 821
DESCRIPTION- KUMAR, J. BIOL. CHEM., (1999), vol. 274, pages 24137 - 24141
DESCRIPTION- KUNDU ET AL., 3 BIOTECH., (2013), vol. 3, pages 225 - 234
DESCRIPTION- LENK ET AL., PLOS GENETICS, (2011), vol. 7, page EL002104
DESCRIPTION- LEWIS, J. OF GENERAL VIROLOGY, (2006), vol. 87, pages 2443 - 2449
DESCRIPTION- LUNDQUIST ET AL., "Site-directed mutagenesis and characterization of uracil-DNA glycosylase inhibitor protein. Role of specific carboxylic amino acids in complex formation with Escherichia coli uracil-DNA glycosylase", J. BIOL. CHEM., (1997), vol. 272, pages 21408 - 21419
DESCRIPTION- LUNDQUIST, "Site-directed mutagenesis and characterization of uracil-DNA glycosylase inhibitor protein. Role of specific carboxylic amino acids in complex formation with Escherichia coli uracil-DNA glycosylase", J. BIOL. CHEM., (1997), vol. 272, pages 21408 - 21419
DESCRIPTION- MALI, P. ET AL., "RNA-guided human genome engineering via Cas9", SCIENCE, (2013), vol. 339, pages 823 - 826
DESCRIPTION- MCDONALD, GENOMICS, (1997), vol. 39, pages 402 - 405
DESCRIPTION- MINORETTI, INT. J. OF MOL. MED., (2007), vol. 19, pages 369 - 372
DESCRIPTION- NORIS, BRITISH JOURNAL OF HAEMATOLOGY, (1997), vol. 97, pages 312 - 320
DESCRIPTION- POLLER ET AL., GENOMICS, (1993), vol. 17, pages 740 - 743
DESCRIPTION- QI, CELL, (20121228), vol. 152, no. 5, pages 1173 - 83
DESCRIPTION- QI, CELL., (20121228), vol. 152, no. 5, pages 1173 - 83
DESCRIPTION- RAVISHANKAR ET AL., "X-ray analysis of a complex of Escherichia coli uracil DNA glycosylase (EcUDG) with a proteinaceous inhibitor. The structure elucidation of a prokaryotic UDG", NUCLEIC ACIDS RES., (1998), vol. 26, pages 4880 - 4887
DESCRIPTION- WANG ET AL., "Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase", J. BIOL. CHEM., (1989), vol. 264, pages 1163 - 1171
DESCRIPTION- WEINBERGER, THE J. OF PHYSIOLOGY, (2012), vol. 590, pages 3449 - 3464
DESCRIPTION- YAZAKI, KIDNEY INT, (2003), vol. 64, pages 11 - 16
DESCRIPTION- PUTNAM ET AL., "Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase", J. MOL. BIOL., (1999), vol. 287, doi:doi:10.1006/jmbi.1999.2605, pages 331 - 346, XP004462617
DESCRIPTION- CHEN, "Fusion protein linkers: property, design and functionality", ADV DRUG DELIV REV., (2013), vol. 65, no. 10, doi:doi:10.1016/j.addr.2012.09.039, pages 1357 - 69, XP055341428
DESCRIPTION- QI ET AL., "Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression", CELL, (2013), vol. 152, no. 5, doi:doi:10.1016/j.cell.2013.02.022, pages 1173 - 83, XP055346792
DESCRIPTION- QI, "Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression", CELL, (20121228), vol. 152, no. 5, doi:doi:10.1016/j.cell.2013.02.022, pages 1173 - 83, XP055346792
DESCRIPTION- GILBERT ET AL., "CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes", CELL, (2013), vol. 154, no. 2, doi:doi:10.1016/j.cell.2013.06.044, pages 442 - 51, XP055321615
DESCRIPTION- WU, "Correction of a genetic disease in mouse via use of CRISPR-Cas9", CELL STEM CELL, (2013), vol. 13, doi:doi:10.1016/j.stem.2013.10.016, pages 659 - 662, XP055196555
DESCRIPTION- SCHWANK, "Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients", CELL STEM CELL, (2013), vol. 13, doi:doi:10.1016/j.stem.2013.11.002, pages 653 - 658, XP055102691
DESCRIPTION- DELTCHEVA E.; CHYLINSKI K.; SHARMA C.M.; GONZALES K.; CHAO Y.; PIRZADA Z.A.; ECKERT M.R.; VOGEL J.; CHARPENTIER E., "CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.", NATURE, (2011), vol. 471, doi:doi:10.1038/nature09886, pages 602 - 607, XP055308803
DESCRIPTION- KLEINSTIVER, B. P. ET AL., "Engineered CRISPR-Cas9 nucleases with altered PAM specificities", NATURE, (2015), vol. 523, doi:doi:10.1038/nature14592, pages 481 - 485, XP055293257
DESCRIPTION- KLEINSTIVER, B.P. ET AL., "High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.", NATURE, (2016), vol. 529, doi:doi:10.1038/nature16526, pages 490 - 495, XP055303390
DESCRIPTION- KOMOR, A.C. ET AL., "Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage", NATURE, (2016), vol. 533, doi:doi:10.1038/nature17946, pages 420 - 424, XP055343871
DESCRIPTION- HWANG, W.Y. ET AL., "Efficient genome editing in zebrafish using a CRISPR-Cas system", NATURE BIOTECHNOLOGY, (2013), vol. 31, doi:doi:10.1038/nbt.2501, pages 227 - 229, XP055086625
DESCRIPTION- JIANG, W. ET AL., "RNA-guided editing of bacterial genomes using CRISPR-Cas systems", NATURE BIOTECHNOLOGY, (2013), vol. 31, doi:doi:10.1038/nbt.2508, pages 233 - 239, XP055249123
DESCRIPTION- MALI ET AL., "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", NAT BIOTECH OL., (2013), vol. 31, no. 9, doi:doi:10.1038/nbt.2675, pages 833 - 8, XP055294730
DESCRIPTION- PRASHANT, "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", NATURE BIOTECHNOLOGY, (2013), vol. 31, no. 9, doi:doi:10.1038/nbt.2675, pages 833 - 838, XP055294730
DESCRIPTION- PRASHANT ET AL., "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", NATURE BIOTECHNOLOGY, (2013), vol. 31, no. 9, doi:doi:10.1038/nbt.2675, pages 833 - 838, XP055294730
DESCRIPTION- TSAI SQ; WYVEKENS N; KHAYTER C; FODEN JA; THAPAR V; REYON D; GOODWIN MJ; ARYEE MJ; JOUNG JK, "Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing", NAT BIOTECHNOL., (2014), vol. 32, no. 6, doi:doi:10.1038/nbt.2908, pages 569 - 76, XP055178523
DESCRIPTION- GUILINGER JP; THOMPSON DB; LIU DR, "Fusion of catalytically inactive Cas9 to Fokl nuclease improves the specificity of genome modification", NAT. BIOTECHNOL., (2014), vol. 32, no. 6, doi:doi:10.1038/nbt.2909, pages 577 - 82, XP055157221
DESCRIPTION- KLEINSTIVER, B. P. ET AL., "Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition", NATURE BIOTECHNOLOGY, (2015), vol. 33, doi:doi:10.1038/nbt.3404, pages 1293 - 1298, XP055309933
DESCRIPTION- MAEDER ET AL., "CRISPR RNA-guided activation of endogenous human genes", NAT METHODS, (2013), vol. 10, doi:doi:10.1038/nmeth.2598, pages 977 - 979, XP055291599
DESCRIPTION- FERRETTI ETCIL., J.J.; MCSHAN W.M.; AJDIC D.J.; SAVIC D.J.; SAVIC G.; LYON K.; PRIMEAUX C.; SEZATE S.; SUVOROV A.N.; KENTON S., "Complete genome sequence of an M1 strain of Streptococcus pyogenes", PROC. NATL. ACAD. SCI. U.S.A., (2001), vol. 98, doi:doi:10.1073/pnas.071559398, pages 4658 - 4663, XP002344854
DESCRIPTION- FERRETTI J.J.; MCSHAN W.M.; AJDIC D.J.; SAVIC D.J.; SAVIC G.; LYON K.; PRIMEAUX C.; SEZATE S.; SUVOROV A.N.; KENTON S., "Complete genome sequence of an M1 strain of Streptococcus pyogenes.", PROC. NATL. ACAD. SCI. U.S.A., (2001), vol. 98, doi:doi:10.1073/pnas.071559398, pages 4658 - 4663, XP002344854
DESCRIPTION- JINEK M.; CHYLINSKI K.; FONFARA I.; HAUER M.; DOUDNA J.A.; CHARPENTIER E., "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.", SCIENCE, (2012), vol. 337, doi:doi:10.1126/science.1225829, pages 816 - 821, XP055299674
DESCRIPTION- SLAYMAKER, I.M. ET AL., "Rationally engineered Cas9 nucleases with improved specificity.", SCIENCE, (2015), vol. 351, doi:doi:10.1126/science.aad5227, pages 84 - 88, XP002757561
DESCRIPTION- CHYLINSKI; RHUN; CHARPENTIER, "The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems", RNA BIOLOGY, (2013), vol. 10, no. 5, doi:doi:10.4161/rna.24321, pages 726 - 737, XP055116068
INTERNATIONAL-SEARCH-REPORT- ALEXIS C. KOMOR ET AL, "Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage", NATURE, United Kingdom, (20160420), vol. 533, no. 7603, doi:10.1038/nature17946, ISSN 0028-0836, pages 420 - 424, XP055343871 [XP] 1-30,44-106,128-190,193-283,299-302 * abstract * * page 420 - page 423 *
OPPOSITION- Haeussler Maximilian; Concordet Jean-Paul, "Genome Editing with CRISPR-Cas9: Can It Get Any Better?", Journal of Genetics and Genomics, Elsevier Ltd., AMSTERDAM, NL, AMSTERDAM, NL , (20160424), vol. 43, no. 5, doi:10.1016/j.jgg.2016.04.008, ISSN 1673-8527, pages 239 - 250, XP029560563
OPPOSITION- Momose Tsuyoshi; Concordet Jean-Paul, "Diving into marine genomics with CRISPR/Cas9 systems", Marine Genomics, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20161012), vol. 30, doi:10.1016/j.margen.2016.10.003, ISSN 1874-7787, pages 55 - 65, XP029848081
OPPOSITION- Plosky Brian S., "CRISPR-Mediated Base Editing without DNA Double-Strand Breaks", Molecular Cell, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19000101), vol. 62, no. 4, doi:10.1016/j.molcel.2016.05.006, ISSN 1097-2765, pages 477 - 478, XP029552452
OPPOSITION- Plosky Brian S., "CRISPR-Mediated Base Editing without DNA Double-Strand Breaks", Molecular Cell, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20160519), vol. 62, no. 4, doi:10.1016/j.molcel.2016.05.006, ISSN 1097-2765, pages 477 - 478, XP029552452
OPPOSITION- Tycko Josh; Myer Vic E.; Hsu Patrick D., "Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity", Molecular Cell, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20160804), vol. 63, no. 3, doi:10.1016/j.molcel.2016.07.004, ISSN 1097-2765, pages 355 - 370, XP029675847
OPPOSITION- Jeong You Kyeong, Song Beomjong, Bae Sangsu, "Current Status and Challenges of DNA Base Editing Tools", Molecular Therapy, Elsevier Inc., US, US , (20200901), vol. 28, no. 9, doi:10.1016/j.ymthe.2020.07.021, ISSN 1525-0016, pages 1938 - 1952, XP055906045
OPPOSITION- Aj Kueh, Et Al., "The new editor - targeted genome engineering in the absence of homology-directed repair", Cell Death Discovery, (20160613), vol. 2, no. 1, doi:10.1038/cddiscovery.2016.42, pages 1 - 2, XP055593859
OPPOSITION- Kueh A.J., Herold M.J., "The new editor—targeted genome engineering in the absence of homology-directed repair", Cell Death Discovery, Nature Publishing Group, UK, UK , vol. 2, no. 1, doi:10.1038/cddiscovery.2016.42, ISSN 2058-7716, page 16042, XP093185260
OPPOSITION- Benjamin P. Kleinstiver, Pattanayak Vikram, Prew Michelle S., Tsai Shengdar Q., Nguyen Nhu T., Zheng Zongli, Joung J. Keith, "High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects", Nature, (20160128), vol. 529, no. 7587, doi:10.1038/nature16526, pages 490 - 495, XP055303390
OPPOSITION- Benjamin P. Kleinstiver, Pattanayak Vikram, Prew Michelle S., Tsai Shengdar Q., Nguyen Nhu T., Zheng Zongli, Joung J. Keith, "High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects", Nature, (20160128), vol. 529, no. 7587, doi:10.1038/nature16526, pages 490 - 495, XP055303390
OPPOSITION- Alexis C. Komor, Yongjoo B. Kim, Michael S. Packer, John A. Zuris, David R. Liu, "Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage", Nature, (20160501), vol. 533, no. 7603, doi:10.1038/nature17946, pages 420 - 424, XP055481330
OPPOSITION- Komor Alexis C., Kim Yongjoo B., Packer Michael S., Zuris John A., Liu David R., "Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage", Nature, (20160519), vol. 533, no. 7603, doi:10.1038/nature17946, pages 420 - 424, XP093078921
OPPOSITION- Yunqing Ma, Jiayuan Zhang, Weijie Yin, Zhenchao Zhang, Yan Song, Xing Chang, "Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells", Nature Methods, Nature Publishing Group US, New York, New York, (20161201), vol. 13, no. 12, doi:10.1038/nmeth.4027, ISSN 1548-7091, pages 1029 - 1035, XP055573969
OPPOSITION- Nishida K., Arazoe T., Yachie N., Banno S., Kakimoto M., Tabata M., Mochizuki M., Miyabe A., Araki M., Hara K. Y., Shimatani Z., Kondo A., "Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems", Science, American Association for the Advancement of Science, US, US , (20160916), vol. 353, no. 6305, doi:10.1126/science.aaf8729, ISSN 0036-8075, pages aaf8729 - aaf8729, XP055851479
OPPOSITION- Nishida K., Arazoe T., Yachie N., Banno S., Kakimoto M., Tabata M., Mochizuki M., Miyabe A., Araki M., Hara K. Y., Shimatani Z., Kondo A., "Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems", Science, American Association for the Advancement of Science, US, US , (20160916), vol. 353, no. 6305, doi:10.1126/science.aaf8729, ISSN 0036-8075, XP055851479
OPPOSITION- Haifeng Wang, Marie La Russa, Lei S. Qi, "CRISPR/Cas9 in Genome Editing and Beyond", ANNUAL REVIEW OF BIOCHEMISTRY, PALTO ALTO, CA, US, US , (20160602), vol. 85, no. 1, doi:10.1146/annurev-biochem-060815-014607, ISSN 0066-4154, pages 227 - 264, XP055290311

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents